COSMOS Pharmaceutical Corporation
3349.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥31 | ¥31 | ¥24 | ¥24 |
| Dep. & Amort. | ¥22 | ¥22 | ¥20 | ¥17 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥3 | -¥3 | ¥10 | ¥13 |
| Other Non-Cash | ¥3 | ¥3 | ¥1 | ¥0 |
| Operating Cash Flow | ¥52 | ¥52 | ¥55 | ¥54 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥53 | -¥53 | -¥56 | -¥47 |
| Net Acquisitions | ¥0 | ¥0 | ¥1 | ¥0 |
| Inv. Purchases | -¥1 | -¥1 | -¥1 | -¥1 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Inv. Act. | -¥2 | -¥2 | -¥2 | -¥2 |
| Investing Cash Flow | -¥55 | -¥55 | -¥57 | -¥49 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥13 | ¥13 | ¥13 | ¥7 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥0 | -¥0 | ¥0 | -¥0 |
| Dividends Paid | -¥5 | -¥5 | -¥5 | -¥3 |
| Other Fin. Act. | -¥0 | -¥0 | -¥0 | -¥0 |
| Financing Cash Flow | ¥8 | ¥8 | ¥9 | ¥3 |
| Forex Effect | ¥0 | ¥0 | ¥0 | -¥0 |
| Net Chg. in Cash | ¥5 | ¥5 | ¥6 | ¥9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥52 | ¥52 | ¥46 | ¥37 |
| End Cash | ¥57 | ¥57 | ¥52 | ¥46 |
| Free Cash Flow | -¥1 | -¥1 | -¥1 | ¥8 |